Search Results 601-610 of 18168 for Lymphocytic leukemia
Epidemiology of Chronic Lymphocytic Leukemia. Rochester, Minn. The overall ... leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations.
Cancer treatment, Immunotherapy, Targeted drug therapy, Chronic lymphocytic leukemia, Small lymphocytic lymphoma. Allison C ...
Rituximab-abbs injection is used together with other cancer medicines (eg, fludarabine and cyclophosphamide) to treat chronic lymphocytic leukemia (CLL).
... lymphocytic leukemia (CLL): the Mayo Clinic experience. Blood Cancer J 2026 Jan 7; 16 (1):7 Epub 2026 Jan 07. View PubMed; Saifi O, Lester SC, Rule WG, Breen ...
Lymphoma is a blood cancer that begins when a germ-fighting white blood cell, called a lymphocyte, mutates and rapidly multiplies. There were roughly a half ...
... CLL defined by 2008 International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria; Must have received one prior therapy for CLL; Must meet one or ...
Hodgkin lymphoma usually arises from B lymphocytes. Non-Hodgkin lymphomas can arise from B lymphocytes, T lymphocytes or natural killer cells. Hodgkin ...
Acute lymphocytic leukemia, Myelodysplastic syndromes, Acute myelogenous leukemia, Chronic myelomonocytic leukemia ... Bone marrow transplant, CAR-T cell therapy, ...
A study has identified more precise assessment measures for people newly diagnosed with chronic lymphocytic leukemia. Researchers are developing ways to ...
... lymphocytic leukemia (CLL) with 17p deletion. An increased rate of deaths and serious adverse events (SAEs) among participants with front-line CLL and early ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.